BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806X902. A total of 3 filers reported holding BRIDGEBIO PHARMA INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,032 | +37.0% | 304,600 | -10.6% | 0.01% | +20.0% |
| Q2 2023 | $5,861 | +56.8% | 340,800 | +51.2% | 0.01% | +66.7% |
| Q1 2023 | $3,737 | +519.7% | 225,400 | +184.6% | 0.00% | +200.0% |
| Q4 2022 | $603 | -99.8% | 79,200 | +130.2% | 0.00% | – |
| Q3 2022 | $341,000 | -58.1% | 34,400 | -61.6% | 0.00% | -100.0% |
| Q2 2022 | $814,000 | -35.9% | 89,700 | -28.4% | 0.00% | 0.0% |
| Q1 2022 | $1,270,000 | -63.0% | 125,200 | -39.1% | 0.00% | -66.7% |
| Q4 2021 | $3,429,000 | +28475.0% | 205,600 | +102700.0% | 0.00% | – |
| Q3 2021 | $12,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q2 2021 | $6,000 | -90.2% | 100 | +900.0% | 0.00% | – |
| Q1 2021 | $61,000 | -94.1% | 10 | -93.2% | 0.00% | -100.0% |
| Q4 2020 | $1,038,000 | -33.7% | 146 | -69.6% | 0.00% | -50.0% |
| Q2 2020 | $1,565,000 | +1322.7% | 480 | +1163.2% | 0.00% | – |
| Q1 2020 | $110,000 | – | 38 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 105,900 | $3,453,000 | 0.02% |
| SIMPLEX TRADING, LLC | 480 | $1,565,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |